FibroGen Inc (FGEN) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
FibroGen Inc (FGEN) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $26.00K (capex $13.00K plus investments $-13.00K) from operating cash flow of $12.68 Million. See FGEN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$26.00K
Capex + Investments
Operating Cash Flow
$12.68 Million
USD
Capital Expenditures
$13.00K
USD
FibroGen Inc Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for FibroGen Inc across 4 annual periods. For the full cash flow conversion analysis, see FibroGen Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for FibroGen Inc (2013–2020)
Year-by-year capital reinvestment analysis for FibroGen Inc. See FGEN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 5.78x | $471.50 Million | $81.60 Million | $3.99 Million | ▲ +350.0% |
| 2016 | 1.28x | $9.13 Million | $7.11 Million | $1.25 Million | ▼ -73.2% |
| 2014 | 4.79x | $107.30 Million | $22.41 Million | $8.12 Million | ▲ +1723.0% |
| 2013 | 0.26x | $6.81 Million | $25.92 Million | $6.81 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow